🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
1237.5.01038 Boehringer Ingelheim Investigational Site
Start Date
2011-09
Trial ID
NCT01431274
Treatments Being Tested
This efficacy and safety study compares four different combinations of blin...
Status
Completed
Location
1249.1.32003 Boehringer Ingelheim Investigational Site
Start Date
2007-10
Trial ID
NCT00535366
Treatments Being Tested
The primary objective is to compare the systemic exposure to tiotropium and...
Status
Completed
Location
1298.2.1 Boehringer Ingelheim Investigational Site
Start Date
2011-03
Trial ID
NCT01309139
Treatments Being Tested
The objective of the trial is to compare the lung function profile of once ...
Status
Completed
Location
1237.11.32002 Boehringer Ingelheim Investigational Site
Start Date
2013-10
Trial ID
NCT01969721
Study to obtain information about the safety and tolerability of tiotropium...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT02172534
Treatments Being Tested
The aim of this trial is to evaluate the safety and efficacy of 2.5 and 5 µ...
Status
Completed
Location
205.464.81020 Boehringer Ingelheim Investigational Site
Start Date
2011-04
Trial ID
NCT01340209
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-07-28
Trial ID
NCT02242266
The overall objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
1237.6.01106 Boehringer Ingelheim Investigational Site
Start Date
2011-09
Trial ID
NCT01431287
Treatments Being Tested
The study is intended to characterize the lung function profile of BI1744 i...
Status
Completed
Location
1222.39.32003 Boehringer Ingelheim Investigational Site
Start Date
2010-01
Trial ID
NCT01040689
The primary objective of this trial is to investigate the effect of 6 weeks...
Status
Completed
Location
1237.13.01302 Boehringer Ingelheim Investigational Site
Start Date
2012-03
Trial ID
NCT01533922
Treatments Being Tested